Financials

v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 23,686 $ 13,724
Investments 123,339 7,182
Restricted cash 285 192
Prepaid expenses and other current assets 1,001 2,448
Total current assets 148,311 23,546
Restricted cash 385 478
Property and equipment, net 671 973
Operating lease right of use assets 2,612 3,063
Other assets 0 212
Total assets 151,979 28,272
Current liabilities:    
Notes payable 77 301
Accounts payable 1,152 3,179
Accrued expenses 10,488 11,030
Derivative liability 0 39
Operating lease liabilities, current 1,519 1,437
Loan payable 10,744 15,908
Total current liabilities 23,980 31,894
Other long-term liabilities 0 44
Operating lease liabilities, noncurrent 2,456 3,239
Total liabilities 26,436 35,177
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no sharesissued and outstanding at June 30, 2024 and December 31, 2023. 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized,11,498,917 and 4,423,683 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 1 0
Additional paid-in capital 579,510 429,780
Accumulated deficit (453,580) (436,684)
Accumulated other comprehensive loss (388) (1)
Total stockholders equity (deficit) 125,543 (6,905)
Total liabilities and stockholders’ equity $ 151,979 $ 28,272

Source

v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 6,865 $ 4,249 $ 12,627 $ 17,637
General and administrative 4,123 3,940 7,984 7,849
Total operating expenses 10,988 8,189 20,611 25,486
Operating loss (10,988) (8,189) (20,611) (25,486)
Other income (expense), net:        
Other income, net 695 183 3,604 412
Interest income 906 232 1,568 494
Interest expense (652) (1,008) (1,491) (1,948)
Change in fair value of derivative liability 11 0 39 0
Foreign currency transaction (loss) gain, net 31 (2) (5) (1)
Other income (expense), net 991 (595) 3,715 (1,043)
Net loss $ (9,997) $ (8,784) $ (16,896) $ (26,529)
Net loss per share, basic $ (0.9) $ (2.05) $ (1.75) $ (6.27)
Net loss per share, diluted $ (0.9) $ (2.05) $ (1.75) $ (6.27)
Weighted average number of common shares outstanding, basic 11,053,241 4,277,701 9,681,875 4,229,894
Weighted average number of common shares outstanding, diluted 11,053,241 4,277,701 9,681,875 4,229,894
Comprehensive loss:        
Net Income (Loss) $ (9,997) $ (8,784) $ (16,896) $ (26,529)
Other comprehensive (loss) income :        
Change in unrealized (loss) gain on marketable debt securities (59) 45 (387) 103
Total other comprehensive (loss) income (59) 45 (387) 103
Total comprehensive loss $ (10,056) $ (8,739) $ (17,283) $ (26,426)

Source

v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss $ (16,896) $ (26,529)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,270 1,850
Depreciation expense 302 340
Net amortization on discount of investments (1,867) (279)
Amortization of debt discount 320 430
Other (41) (2)
Changes in operating assets and liabilities:    
Decrease (increase) in prepaid expenses and other current assets 1,653 (699)
Decrease (increase) in other assets 212 (57)
Decrease in operating lease right of use asset 451 398
(Decrease) increase in other long-term liabilities (44) 2,500
Decrease in accounts payable (2,027) (664)
(Decrease) increase in accrued expenses (542) 420
Decrease in operating lease liabilities (701) (624)
Net cash used in operating activities (16,910) (22,916)
Cash flows from investing activities:    
Purchases of investments (130,725) (23,930)
Proceeds from sales and maturities of investments 16,050 38,287
Net cash (used in) provided by investing activities (114,675) 14,357
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 146,130 207
Repayment of notes payable (224) (302)
Repayment of long-term borrowings (4,359) 0
Net cash provided by (used in) financing activities 141,547 (95)
Net increase (decrease) in cash, cash equivalents, and restricted cash 9,962 (8,654)
Cash, cash equivalents, and restricted cash at beginning of the period 14,394 17,673
Cash, cash equivalents, and restricted cash at end of the period 24,356 9,019
Supplemental disclosure of cash flow information and non-cash transactions:    
Cash paid during the period for interest 984 1,322
Proceeds from issuance of common stock not yet received 0 41
Write off of fully depreciated property and equipment 0 178
Common stock issuance costs not yet paid 75 0
Issuance of common stock for conversion of convertible debt $ 1,125 $ 875

Source